There’s a lot of research around Type 2 diabetes that has informed patient care when it comes to diagnosis, treatment, and lifestyle management. But much less is known about Type 1, long mislabeled “childhood diabetes.” Johns Hopkins epidemiologists Elizabeth Selvin and Michael Fang talk with Stephanie Desmon about new research debunking a lot of previously held assumptions about Type 1 diabetes, the prevalence of adult onset and correlation with obesity, and why different approaches to diagnosis and management are necessary. They also discuss the cost of insulin and why more research is needed around medications like Ozempic for Type 1 diabetes.